Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1999-3-18
pubmed:abstractText
Effects of voglibose (an alpha-glucosidase inhibitor) and pioglitazone (an insulin sensitizer) on glycemic control and on the function of pancreatic islets were evaluated using Goto-Kakizaki (GK) rats with non-insulin-dependent diabetes mellitus (NIDDM). Five week administration (8-13 weeks of age in GK rats) of voglibose alone (added to the chow at a concentration of 10 ppm), pioglitazone alone (10 mg/kg daily p.o.), or both of the agents together significantly improved fasting plasma glucose levels and those at 120 min in oral glucose tolerance tests. Insulin secretory capacity in response to glucose of the isolated islets, assessed by batch incubation, was significantly improved in the voglibose and in the voglibose plus pioglitazone groups. Eight-week administration (5-13 weeks of age) of voglibose and voglibose plus pioglitazone successfully lowered the fasting levels of plasma glucose and triglyceride. The glucose-responsiveness in insulin release from the islets was also significantly recovered by the therapy. The treatment increased the insulin content of the islets to almost twice that in untreated controls. Thus, treatment by these drugs can not only effectively ameliorate the metabolic derangement of NIDDM in GK rats, but it can also restore the deteriorated islet function, possibly through protection from glucose toxicity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0018-5043
pubmed:author
pubmed:issnType
Print
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
673-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:9918384-Animals, pubmed-meshheading:9918384-Blood Glucose, pubmed-meshheading:9918384-Cholesterol, pubmed-meshheading:9918384-Diabetes Mellitus, Type 2, pubmed-meshheading:9918384-Enzyme Inhibitors, pubmed-meshheading:9918384-Fasting, pubmed-meshheading:9918384-Glucose Tolerance Test, pubmed-meshheading:9918384-Hypoglycemic Agents, pubmed-meshheading:9918384-Inositol, pubmed-meshheading:9918384-Insulin, pubmed-meshheading:9918384-Islets of Langerhans, pubmed-meshheading:9918384-Male, pubmed-meshheading:9918384-Rats, pubmed-meshheading:9918384-Rats, Mutant Strains, pubmed-meshheading:9918384-Rats, Wistar, pubmed-meshheading:9918384-Thiazoles, pubmed-meshheading:9918384-Thiazolidinediones, pubmed-meshheading:9918384-Triglycerides, pubmed-meshheading:9918384-alpha-Glucosidases
pubmed:year
1998
pubmed:articleTitle
Beneficial effect of long-term combined treatment with voglibose and pioglitazone on pancreatic islet function of genetically diabetic GK rats.
pubmed:affiliation
Department of Metabolism and Clinical Nutrition, Kyoto University School of Medicine, Japan. ygb03614@nifty.ne.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't